JCAR17 | BMY Message Board Posts

Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1123 of 3718  at  12/7/2019 4:39:37 PM  by

stockmd


 In response to msg 1120 by  cptspr
view thread

Re: JCAR17

My understanding is that the continued low incidence of CRS and neuropathy associated with JCAR17 would support outpatient administration, which would be a big advantage for patients, the healthcare system and insurers.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 8     Views: 250
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...